“…After the screening, eligible individuals, who agreed to take part in the trial, underwent an additional comprehensive assessment on psychosocial health and associated factors (baseline assessment), including, among others, measures on generalized anxiety (GAD-7, [ 21 ]), severity of somatic symptoms (PHQ-15, [ 22 ]), general self-efficacy (GSE, [ 23 ]); self-stigma (Self-stigma of Mental Illness Scale–Short Form, SSMIS-SF, [ 24 ]); social support (short form of the Lubben Social Network Scale, LSNS-6, [ 25 ]; ENRICHD Social Support Inventory, ESSI, [ 26 ]); and health-related quality of life and health status (5-level version of EQ-5D and EQVAS, EQ-5D-5L, [ 27 ]). Please see the aforementioned study protocol for further information [ 13 ].…”